Glycerol phenylbutyrate and Insulin Degludec (U-100) Prefilled Pens
Determining the interaction of Glycerol phenylbutyrate and Insulin Degludec (U-100) Prefilled Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycerol phenylbutyrate
Brand name: Ravicti
Synonyms: n.a.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycerol phenylbutyrate-Insulin Degludec (U-100) Vials
- Glycerol phenylbutyrate-Insulin Degludec (U-200) Prefilled Pens
- Glycerol phenylbutyrate-Insulin degludec and liraglutide
- Glycerol phenylbutyrate-Insulin degludec and liraglutide Subcutaneous
- Glycerol phenylbutyrate-Insulin degludec Subcutaneous
- Glycerol phenylbutyrate-Insulin detemir
- Insulin Degludec (U-100) Prefilled Pens-GlycoLax
- Insulin Degludec (U-100) Prefilled Pens-Glycophos
- Insulin Degludec (U-100) Prefilled Pens-Glycophos Injection
- Insulin Degludec (U-100) Prefilled Pens-Glycopyrrolate
- Insulin Degludec (U-100) Prefilled Pens-Glycopyrrolate (Oral Inhalation)
- Insulin Degludec (U-100) Prefilled Pens-Glycopyrrolate (Systemic)